The most important first step is to contain the damage and time is critical. Immediately freeze their bank and custodial accounts because it is likely the breach happened a long time ago and the ...
MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss the clinical evidence strategy for submission of a Biologic License ...
A Case Study on How Brand Equity and Service Quality Shape Revisit Intention in Luxury Hospitality The hospitality industry is rapidly evolving through digital transformation, giving rise to hybrid ...
The future of Nippon Shinyaku’s Duchenne muscular dystrophy (DMD) therapy Viltepso has been thrown into doubt after it failed a clinical trial designed to upgrade its 2020 accelerated approval. The ...
The registry data suggest improved outcomes without safety concerns, but confirmatory RCTs are needed, a researcher says.
Rezdiffra FDA approval fuels sales; expansion to F4 MASH cirrhosis with 2027 trial data. Read more about MDGL stock here.
Tao, J. and Ke, Y. (2026) Facilitating or Inhibiting: A Cross-Level Study of the Impact of Artificial Intelligence Usage on Employees’ Thriving at Work. Open Journal of Business and Management, 14, ...
Pfizer Inc. today announced positive results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, ...
Zacks.com on MSN
5 Small Drug Stocks to Buy as Industry Recovery Picks Up
Innovation is at its peak in the Zacks Medical-Drugs industry. SLNO, NKTR, RIGL, IRWD and MRKR may prove to be good additions ...
13h
Insurance data can help fill gaps between longer medical trials for patients up against the clock
Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...
M+ cash runway to 2029, bitopertin FDA NDA/accelerated approval catalyst, and DISC-0974 myelofibrosis data—read now.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback